Abstract
Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Chemistry |
Vol/bind | 56 |
Udgave nummer | 10 |
Sider (fra-til) | 1580-91 |
Antal sider | 12 |
ISSN | 0009-9147 |
DOI | |
Status | Udgivet - 1 okt. 2010 |